244 related articles for article (PubMed ID: 15375545)
1. Molecular cytogenetic characterization shows higher genetic homogeneity in conventional renal cell carcinoma compared to other kidney cancers.
Alimov A; Sundelin B; Bergerheim U; Pavlenko M; Pisa P; Zetterberg A; Larsson C; Lagercrantz S
Int J Oncol; 2004 Oct; 25(4):955-60. PubMed ID: 15375545
[TBL] [Abstract][Full Text] [Related]
2. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic alterations in renal tumors: a study of 38 Southeast Asian patients.
Lau LC; Tan PH; Chong TW; Foo KT; Yip S
Cancer Genet Cytogenet; 2007 May; 175(1):1-7. PubMed ID: 17498551
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of renal cell carcinoma by CGH, multicolor-FISH and conventional cytogenic banding analysis.
Sanjmyatav J; Schubert J; Junker K
Oncol Rep; 2005 Nov; 14(5):1183-7. PubMed ID: 16211283
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas.
Kardas I; Mrózek K; Babinska M; Krajka K; Hadaczek P; Lubinski J; Roszkiewicz A; Kuziemska E; Limon J
Oncol Rep; 2005 May; 13(5):949-56. PubMed ID: 15809763
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal gains and losses detected by comparative genomic hybridization and proliferation activity in renal cell carcinoma.
Kallio JP; Mahlamäki EH; Helin H; Karhu R; Kellokumpu-Lehtinen P; Tammela TL
Scand J Urol Nephrol; 2004; 38(3):225-30. PubMed ID: 15204376
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal abnormalities in renal cell neoplasms associated with acquired renal cystic disease. A series studied by comparative genomic hybridization and fluorescence in situ hybridization.
Gronwald J; Baur AS; Holtgreve-Grez H; Jauch A; Mosimann F; Jichlinski P; Wauters JP; Cremer T; Guillou L
J Pathol; 1999 Feb; 187(3):308-12. PubMed ID: 10398084
[TBL] [Abstract][Full Text] [Related]
8. A combination of molecular cytogenetic analyses reveals complex genetic alterations in conventional renal cell carcinoma.
Strefford JC; Stasevich I; Lane TM; Lu YJ; Oliver T; Young BD
Cancer Genet Cytogenet; 2005 May; 159(1):1-9. PubMed ID: 15860350
[TBL] [Abstract][Full Text] [Related]
9. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
10. Dissecting karyotypic patterns in renal cell carcinoma: an analysis of the accumulated cytogenetic data.
Höglund M; Gisselsson D; Soller M; Hansen GB; Elfving P; Mitelman F
Cancer Genet Cytogenet; 2004 Aug; 153(1):1-9. PubMed ID: 15325087
[TBL] [Abstract][Full Text] [Related]
11. Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events.
Gronwald J; Störkel S; Holtgreve-Grez H; Hadaczek P; Brinkschmidt C; Jauch A; Lubinski J; Cremer T
Cancer Res; 1997 Feb; 57(3):481-7. PubMed ID: 9012478
[TBL] [Abstract][Full Text] [Related]
12. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors.
Presti JC; Rao PH; Chen Q; Reuter VE; Li FP; Fair WR; Jhanwar SC
Cancer Res; 1991 Mar; 51(5):1544-52. PubMed ID: 1671759
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic and interphase cytogenetic analysis of papillary (chromophilic) renal cell carcinoma.
Kattar MM; Grignon DJ; Wallis T; Haas GP; Sakr WA; Pontes JE; Visscher DW
Mod Pathol; 1997 Nov; 10(11):1143-50. PubMed ID: 9388066
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of microsatellite marker, AP-PCR and CGH studies in primary renal cell carcinoma.
Hoefling C; Schmidt H; Meinhardt M; Lohse A; Taubert H; Fuessel S; Schmidt U; Schuster K; Baretton G; Wirth MP; Meye A
Int J Mol Med; 2004 Jun; 13(6):835-42. PubMed ID: 15138621
[TBL] [Abstract][Full Text] [Related]
16. Trisomy 3 in renal cell carcinoma.
Renshaw AA; Fletcher JA
Mod Pathol; 1997 May; 10(5):481-4. PubMed ID: 9160314
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma.
Yoshida MA; Ohyashiki K; Ochi H; Gibas Z; Pontes JE; Prout GR; Huben R; Sandberg AA
Cancer Res; 1986 Apr; 46(4 Pt 2):2139-47. PubMed ID: 3948185
[TBL] [Abstract][Full Text] [Related]
18. Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification.
Hughson MD; Bigler S; Dickman K; Kovacs G
Mod Pathol; 1999 Mar; 12(3):301-9. PubMed ID: 10102616
[TBL] [Abstract][Full Text] [Related]
19. Genetic characterization of lung metastases in renal cell carcinoma.
Junker K; Sänger J; Schmidt A; Hindermann W; Presselt N; Helfritzsch H; Schubert J
Oncol Rep; 2003; 10(4):1035-8. PubMed ID: 12792766
[TBL] [Abstract][Full Text] [Related]
20. Molecular cytogenetic characterization of primary cultures and established cell lines from non-medullary thyroid tumors.
Foukakis T; Thoppe SR; Lagercrantz S; Dwight T; Weng WH; Svensson A; Höög A; Zedenius J; Wallin G; Lui WO; Larsson C
Int J Oncol; 2005 Jan; 26(1):141-9. PubMed ID: 15586234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
